Yoshihiko Hirao

Department of Urology, Nara Medical University, Japan

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Oncology > Genitourinary Cancers (since 14 August 2007)

All recent recommendations

• 6.0
  Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib.
  Recommended by Yoshihiko Hirao with Kiyohide Fujimoto
  
• 6.0
  Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31.
  Recommended by Yoshihiko Hirao with Kiyohide Fujimoto
  
• 6.0
  Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis.
  Recommended by Yoshihiko Hirao with Kiyohyde Fujimoto
  
• 3.0
  Neoadjuvant docetaxel and capecitabine in patients with high risk prostate cancer.
  Recommended by Yoshihiko Hirao with Kiyohide Fujimoto